Carcinoma: all 6,719 studies

Page 64 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract CarcinomasCompletedNCT00490399Phase 2
• Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With SunitinibCompletedNCT00486538Phase 2
• A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell CarcinomaTerminatedNCT00485563Phase 2
• Laparoscopic Assisted Versus Open Resection for Colorectal CarcinomaCompletedNCT00485316Phase 3
• Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal CarcinomaTerminatedNCT00484601Phase 2
• Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)CompletedNCT00484211Phase 2
• A Study of Neoadjuvant Sutent for Patients With Renal Cell CarcinomaTerminatedNCT00480935Phase 2
• Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney RemovalCompletedNCT00480389Phase 2
• Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cmCompletedNCT00479050Phase 1
• Dendritic Cell Vaccine for High Risk Ovarian Cancer PatientsCompletedNCT00478452Phase 1
• Sorafenib With TACE to Treat Hepatocellular CarcinomaCompletedNCT00478374Phase 1
• Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)CompletedNCT00478114Phase 3
• Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and NeckCompletedNCT00474825Phase 1
• Intravascular Ultrasound for Hepatocellular Carcinoma StagingStatus unknownNCT00474734
• A Phase I Study of Intraperitoneal Hyperthermic DocetaxelCompletedNCT00474669Phase 1
• Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma PatientsCompletedNCT00471965Phase 3
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedNCT00470496Phase 1
• Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
• Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the BreastStatus unknownNCT00470236Not applicable
• Treatment Study Using Bevacizumab for Patients With Adrenocortical CarcinomaWithdrawnNCT00469469Phase 2
• Hypofractionated Radiotherapy for Small Cell Lung CancerCompletedNCT00469222Phase 1
• Cone Beam CT Scanning in Lung and Bladder Cancer.CompletedNCT00469066
• Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular CarcinomaCompletedNCT00467974Phase 3
• AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With SorafenibCompletedNCT00467025Phase 2
• Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or LymphomaCompletedNCT00466583Phase 1
• Protein Biomarker in Hepatocellular CarcinomaTerminatedNCT00465842
• Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)CompletedNCT00464919Phase 2
• Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)CompletedNCT00464295Phase 2
• A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the BaseStatus unknownNCT00463359Not applicable
• Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular CarcinomaStatus unknownNCT00460681Phase 3
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
• Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck CancerCompletedNCT00458978Phase 2
• A Phase III Study in Post-operative HBV-related Hepatocellular CarcinomaTerminatedNCT00455091
• Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal CarcinomatosisStatus unknownNCT00454519Phase 2
• Evaluation of 123I-Iodometomidate for Adrenal ScintigraphyCompletedNCT00454103Phase 1/2
• Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00450879Phase 1
• Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's TumorsStatus unknownNCT00449358Not applicable
• A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal CancerCompletedNCT00448721Phase 2
• Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney CancerCompletedNCT00448149Phase 1/2
• Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerCompletedNCT00445042Phase 2
• A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.CompletedNCT00444782Phase 2
• Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell CarcinomaCompletedNCT00444314Phase 2
• Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and NeckCompletedNCT00442455Phase 3
• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney CancerTerminatedNCT00440973Phase 2
• OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine AblationCompletedNCT00439127
• A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver DysfunctionCompletedNCT00437424Phase 1
• Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
• Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung CarcinomaTerminatedNCT00435578Phase 2
• Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal CarcinomaCompletedNCT00431210Phase 1
• Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine CervixCompletedNCT00430144Phase 2
• MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00427102Phase 1
• Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2CompletedNCT00425035Phase 2
• Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
• Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell CarcinomaCompletedNCT00422786Phase 2
• A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaCompletedNCT00422344Phase 1
• A Phase II Study to Treat Subjects With Advanced Renal Cell CarcinomaCompletedNCT00422019Phase 2
• A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00421512Phase 1
• ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell CarcinomaCompletedNCT00420888Phase 2/3
• A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell CarcinomaTerminatedNCT00417677Phase 1/2
• Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast CancerCompletedNCT00416403Phase 2
• A Study of LY2181308 in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT00415155Phase 1/2
• Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck CancerTerminatedNCT00412776Phase 2/3
• Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by SurgeryCompletedNCT00410553Phase 1
• Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
• Efficacy of SU 011248 in Head And Neck CarcinomaTerminatedNCT00408252Phase 2
• ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CarcinomaTerminatedNCT00407407Phase 1
• Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003TerminatedNCT00405873Phase 2
• Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003TerminatedNCT00405561Phase 2/3
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
• Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or PharyngolaryngectomyStatus unknownNCT00396617Phase 1
• Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC FamiliesTerminatedNCT00393224
• Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00390195Phase 1/2
• Simultaneous Integrated Boost (SIB)- IMRTCompletedNCT00389727Phase 2
• Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell CarcinomaCompletedNCT00389285Phase 1/2
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based TherapyCompletedNCT00389155Phase 2/3
• Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT00388063Phase 2
• PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyCompletedNCT00388024
• Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular CarcinomaCompletedNCT00386984Phase 3
• Sorafenib and RAD001 Renal Cell CarcinomaCompletedNCT00384969Phase 1
• A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)Status unknownNCT00384800Phase 2
• Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal CarcinomaCompletedNCT00379262Phase 3
• Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous TumorTerminatedNCT00377247Phase 1
• Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCCCompletedNCT00375661Phase 4
• Effect of the Subconscious on Mohs Micrographic SurgeryCompletedNCT00374062Not applicable
• Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell CarcinomaCompletedNCT00372853Phase 1
• Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal CarcinomaWithdrawnNCT00367718Phase 2
• Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung CancerTerminatedNCT00365183Phase 2
• Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical ResectionCompletedNCT00362713Phase 1
• A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal CarcinomaCompletedNCT00362102Phase 2
• SU011248 in Advanced Hepatocellular CarcinomaCompletedNCT00361309Phase 2
• A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and NeckCompletedNCT00358930Phase 2
• Gemcitabine in Treating Patients With Metastatic Cancer of Unknown PrimaryCompletedNCT00357630Phase 2
• Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCsCompletedNCT00357474Phase 3
• Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube CancerCompletedNCT00357448Phase 1
• Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)CompletedNCT00357422Not applicable
• Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant MelanomaCompletedNCT00356460Phase 1
• Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular CarcinomaCompletedNCT00355862Phase 3
• A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedNCT00355355Phase 3
• Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular CarcinomaTerminatedNCT00355212Phase 3
• Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid CarcinomaTerminatedNCT00354523Phase 1/2

← Carcinoma overview